FibroBiologics, Inc.

0.3884-0.03 (-7.72%)

Oct 29, 4:00:02 PM EDT · NasdaqCM · FBLG · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

16.27M

P/E (TTM)

Basic EPS (TTM)

-0.36

Dividend Yield

Recent Filings

8-K

8/8/25Aug 8, 2025

10-Q

7/31/25Jul 31, 2025

8-K

7/18/25Jul 18, 2025

8-K

7/3/25Jul 3, 2025

8-K

6/16/25Jun 16, 2025

About

FibroBiologics, Inc. operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The company was founded in 2021 and is based in Houston, Texas.

CEO

Mr. Peter O'Heeron

IPO

1/31/2024

Website

https://www.fibrobiologics.com

Employees

Sector

Healthcare

Industry

Biotechnology